Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response

The humoral and cellular response to SARS-CoV-2 mRNA full vaccination and booster dose as well as the impact of the spike variants, including Omicron, are still unclear in patients with multiple myeloma (MM) and those with pre-malignant monoclonal gammopathies. In this study, involving 40 patients,...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	OncoImmunology
المؤلفون الرئيسيون:	Paola Storti, Valentina Marchica, Rosanna Vescovini, Valentina Franceschi, Luca Russo, Laura Notarfranchi, Vincenzo Raimondi, Denise Toscani, Jessica Burroughs Garcia, Federica Costa, Benedetta Dalla Palma, Nicolas Thomas Iannozzi, Gabriella Sammarelli, Gaetano Donofrio, Nicola Giuliani
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Taylor & Francis Group 2022-12-01
الموضوعات:	Multiple myeloma monoclonal gammopathies SARS-CoV-2 spike variants neutralizing antibodies Omicron
الوصول للمادة أونلاين:	https://www.tandfonline.com/doi/10.1080/2162402X.2022.2120275